Quantum Genomics Société Anonyme (EPA:ALQGC)

EPA:ALQGC Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-24.94	-17.36	-16.22
Depreciation & Amortization	0.26	0.39	0.14
Stock-Based Compensation	-	1.57	1.48
Other Operating Activities	0.19	-0.05	1.52
Change in Accounts Receivable	0.06	0.76	-0.82
Change in Accounts Payable	9.21	0.77	1.94
Change in Other Net Operating Assets	-4.99	-3.1	-0.03
Operating Cash Flow	-20.21	-17.02	-11.99
Capital Expenditures	-	-0.05	-0.41
Investment in Securities	-0.03	-	0.01
Investing Cash Flow	-0.15	-0.05	-0.41
Long-Term Debt Issued	0.03	3	0.23
Long-Term Debt Repaid	-	-0.38	-0.34
Total Debt Repaid	-	-0.38	-0.34
Net Debt Issued (Repaid)	0.03	2.62	-0.11
Issuance of Common Stock	17.18	0.85	28.5
Other Financing Activities	-	-0.01	-0.01
Financing Cash Flow	17.21	3.46	28.39
Net Cash Flow	-3.15	-13.6	15.99
Free Cash Flow	-20.21	-17.06	-12.4
Free Cash Flow Margin	-803.67%	-294.17%	-311.89%
Free Cash Flow Per Share	-0.58	-0.63	-0.61
Cash Interest Paid	-	0.01	0.01
Levered Free Cash Flow	-15.73	-10.36	-6.75
Unlevered Free Cash Flow	-15.72	-10.33	-6.75
Change in Working Capital	4.27	-1.57	1.09

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.